Morning Overview on MSN
A targeted drug won approval for a hard-to-treat form of advanced prostate cancer
Men diagnosed with metastatic hormone-sensitive prostate cancer who carry a specific tumor deficiency now have a targeted ...
4don MSN
Should lowest-risk prostate 'cancer' still be called cancer? How changing the name could save lives
A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than ...
A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine ...
Prostate cancer starts in the prostate, a small gland located below the bladder that is responsible for secreting one of the components of semen. Prostate cells may grow out of control and become ...
An expert on prostate cancer gives a brief overview of castrate-resistant prostate cancer. This is a synopsis of an Educated Patient Sound Bites series featuring Alicia Morgans, MD, MPH, of ...
New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors ...
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...
The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...
Findings from 14 studies involving more than 8,000 patients show Prolaris adds insight beyond conventional clinical risk categories ...
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results